Name: Mad Money 04/20/26 | Audio Only
Uploaded: 2026-04-20T23:47:58+00:00
Duration: 2658 s

Speakers

Jim Cramer — Host, Mad Money

Robert Barl

Summary

Jim Cramer analyzes the stock market's resilience amid Middle East tensions, attributing it to bond market stability, Fed rate cut expectations, and the unstoppable AI revolution. He reviews the recent rally led by tech and data center stocks, answers caller questions on individual stocks, and explains his purchase of Johnson & Johnson for his charitable trust. The episode also includes an interview with Definium Therapeutics' CEO about psychedelic drug development and a lightning round of stock picks.

Cramer explains why stocks barely reacted to Iran closing the Strait of Hormuz, citing bond market indifference and Fed policy.
He emphasizes the AI revolution as a key market driver, listing companies across power, chips, infrastructure, models, and chatbots.
Cramer reviews the market rally since March 30th, highlighting tech, consumer discretionary, and data center stocks as top performers.
He answers caller questions on stocks including Berkshire Hathaway, Core, Salesforce, and Applied Materials.
Cramer interviews Definium Therapeutics CEO Robert Barl about LSD-based treatments and a supportive White House executive order.
In the lightning round, Cramer gives quick opinions on AEF, Interdigital, INFQ, Flex, Biogen, and others.
Cramer reveals buying Johnson & Johnson for his charitable trust, citing its discount, new drug approval, and portfolio diversification benefits.
Throughout, Cramer advises against fighting the Fed and chasing parabolic moves, advocating for a mix of hot and cold stocks.

Trade Ideas

Jim Cramer Host, Mad Money 9:55

Berkshire Hathaway's assets are still top-tier.

Berkshire Hathaway's assets are second to none, put together by Warren Buffett and Greg Abel, and leaving the stock now would be a big mistake despite recent underperformance.

Jim Cramer Host, Mad Money 24:50

Core is an aggressive buy but volatile.

Core is an aggressive buy with terrific fundamentals, but it is a new company with lots of debt and will be prone to volatility and roller-coaster moves.

Jim Cramer Host, Mad Money 25:35

Hold Salesforce, it's cheap and bottoming.

Salesforce is incredibly cheap and putting in a bottom; it is a long-term position with positive developments expected by 2030, so there's no need to sell at current prices.

Jim Cramer Host, Mad Money 26:23

Applied Materials, Lam, KLA are buys.

Applied Materials, Lam Research, and KLA are the only way to alleviate semiconductor shortages; they have strong intellectual property and are essential for the semiconductor industry.

Jim Cramer Host, Mad Money 35:40

Buy AEF, it's cheap.

AEF is ridiculously cheap and could do very well; it is a buying opportunity.

Jim Cramer Host, Mad Money 36:16

Interdigital is a buy.

Interdigital is a telco play, not an AI play, but it will work in the current market and is liked by Cramer, especially after a pullback.

Jim Cramer Host, Mad Money 37:05

Take profit on INFQ, buy back lower.

INFQ had a parabolic move after Nvidia's GTC; it is advisable to take some profit now and buy back at a lower price.

Jim Cramer Host, Mad Money 37:54

Wait for pullback in Flex.

Flex is a monster with rising price targets, but it is too high at current levels; wait for a pullback before buying.

Jim Cramer Host, Mad Money 38:29

Biogen and Gilead are attractive.

Biogen looks attractive after an upgrade highlighting multiple revenue streams including Alzheimer's; Gilead is also liked in the biotech space.

Jim Cramer Host, Mad Money 39:40

Buy J&J on weakness for long-term.

Johnson & Johnson is one of the best drug companies, trading at a discount, with a new psoriasis pill approval and spinoffs unlocking value; it provides portfolio diversification away from overheated tech stocks and should be bought on weakness.

Mad Money 04/20/26 | Audio Only

Summary

Trade Ideas

Up Next